• Biomarker Testing (also known as genomic testing or molecular profiling) is especially important for those with cholangiocarcinoma. That’s because CCA is associated with so many biomarkers. Knowing which biomarkers may be driving your cancer can open the door to additional treatment options, including targeted therapies and clinical trials.

• Click here to watch Biomarkers Matter, a video CCF created to explain why biomarker testing is essential.

• Clinical Trials are a critically important option for cholangiocarcinoma patients. They offer the opportunity to access treatments that may become tomorrow's standard of care. 

• Please talk with your doctor about clinical trials. Also ask about “first-line” trials, which include only those patients who have not yet been treated with any other therapies. Determining early on if you qualify for a first-line clinical trial is important because you may not be able to participate once you start on chemotherapy or other treatments.